首页> 外文期刊>European journal of heart failure: journal of the Working Group on Heart Failure of the European Society of Cardiology >Heart failure registry: a valuable tool for improving the management of patients with heart failure.
【24h】

Heart failure registry: a valuable tool for improving the management of patients with heart failure.

机译:心力衰竭注册表:改善心力衰竭患者管理的宝贵工具。

获取原文
获取原文并翻译 | 示例
           

摘要

AIMS: Guidelines on how to diagnose and treat patients with heart failure (HF) are published regularly. However, many patients do not fulfil the diagnostic criteria and are not treated with recommended drugs. The Swedish Heart Failure Registry (S-HFR) is an instrument which may help to optimize the handling of HF patients. METHODS AND RESULTS: The S-HFR is an Internet-based registry in which participating centres (units) can record details of their HF patients directly online and transfer data from standardized forms or from computerized patient documentation. Up to December 2007, 16,117 patients from 78 units had been included in the S-HFR. Of these, 10,229 patients had been followed for at least 1 year, and 2133 deaths were recorded. Online reports from the registry showed that electrocardiograms were available for 97% of the patients. Sinus rhythm was found in 51% of patients and atrial fibrillation in 38%. Echocardiography was performed in 83% of the patients. Overall, 77% of patients were treated with angiotensin converting enzyme inhibitors or angiotensin II receptor blockers, 80% were on beta-blockers, 34% on aldosterone antagonists, and 83% on diuretics. CONCLUSION: The S-HFR is a valuable tool for improving the management of patients with HF, since it enables participating centres to focus on their own potential for improving diagnoses and medical treatment, through the online reports provided.
机译:目的:定期发布有关如何诊断和治疗心力衰竭(HF)的指南。但是,许多患者不符合诊断标准,也没有接受推荐的药物治疗。瑞典心力衰竭登记系统(S-HFR)是一种有助于优化HF患者操作的工具。方法和结果:S-HFR是一个基于Internet的注册表,参与中心(单位)可以在其中直接在线记录其HF患者的详细信息,并从标准化表格或计算机化的患者文档中传输数据。截至2007年12月,S-HFR纳入了来自78个单位的16117名患者。其中,对10,229例患者进行了至少一年的随访,记录了2133例死亡。注册表中的在线报告显示,心电图可用于97%的患者。 51%的患者出现窦性心律,38%的患者发生房颤。 83%的患者进行了超声心动图检查。总体而言,77%的患者接受了血管紧张素转化酶抑制剂或血管紧张素II受体阻滞剂的治疗,80%的患者使用β-受体阻滞剂,34%的患者使用醛固酮拮抗剂,83%的患者使用利尿剂。结论:S-HFR是改善心衰患者管理的有价值的工具,因为它使参与研究的中心能够通过提供的在线报告,专注于自身改善诊断和治疗的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号